Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

Implanet S.A. (IMPZY)

Compare
0.0800
+0.0400
+(100.00%)
At close: April 11 at 4:00:00 PM EDT
Loading Chart for IMPZY
  • Previous Close 0.0400
  • Open 0.0800
  • Bid --
  • Ask --
  • Day's Range 0.0800 - 0.0800
  • 52 Week Range 0.0800 - 0.0800
  • Volume 7,015
  • Avg. Volume 0
  • Market Cap (intraday) 199.95M
  • Beta (5Y Monthly) 1.30
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0500
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Feb 16, 2024
  • 1y Target Est --

Implanet S.A., a medical technology company, manufactures and sells implants for orthopedic surgery. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. The company also provides knee prostheses under the Madison name. The company was founded in 2006 and is based in Martillac, France.

www.implanet.com

40

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IMPZY

View More

Performance Overview: IMPZY

Trailing total returns as of 4/14/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

IMPZY
0.00%
CAC 40 (^FCHI)
1.46%

1-Year Return

IMPZY
0.00%
CAC 40 (^FCHI)
9.21%

3-Year Return

IMPZY
0.43%
CAC 40 (^FCHI)
10.38%

5-Year Return

IMPZY
74.89%
CAC 40 (^FCHI)
60.77%

Compare To: IMPZY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IMPZY

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    14.73M

  • Enterprise Value

    18.61M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -89.65%

  • Return on Assets (ttm)

    -30.18%

  • Return on Equity (ttm)

    -396.55%

  • Revenue (ttm)

    7.45M

  • Net Income Avi to Common (ttm)

    -6.68M

  • Diluted EPS (ttm)

    -0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    248k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.09M

Research Analysis: IMPZY

View More

Company Insights: IMPZY

Research Reports: IMPZY

View More

People Also Watch